Stefan H. E. Kaufmann is Emeritus Director at the Max Planck Institute for Infection Biology in Berlin and continues to be scientifically active as Emeritus Director at the Max Planck Institutes for Infection Biology and for Biophysical Chemistry. He is professor for microbiology and immunology at the Charité University Clinics Berlin, Honorary Professor of the Universidad Peruana Cayetano Heredia, Lima, Peru, Guest Professor at the Tongji University, School of Medicine, Shanghai, China and Visiting Professor at Peking Union Medical College, Beijing, China.
He studied biology at the Johannes Gutenberg University of Mainz. In 1977, he completed his PhD (highest degree, summa cum laude). From 1987 to 1991, he was professor for medical microbiology and immunology and from 1991 to 1998 full professor for immunology at the University of Ulm.
His scientific interests include the immunity to bacterial pathogens with emphasis on tuberculosis and rational vaccine and biomarker design. He is co-developer of a recombinant vaccine candidate against tuberculosis which is about to enter a phase III-clinical trial. He has been coordinator of several international and interdisciplinary research projects.
Stefan Kaufmann holds a Doctor Honoris Causa from the Université de la Méditerranée, Aix-Marseille II. He is the former President and honorary member of the German Society for Immunology. He is a former President of the European Federation of Immunological Societies (EFIS) and a former President of the International Union of Immunological Societies (IUIS).
He published more than 900 publications, mostly in high-ranking journals. He is a highly cited immunologist (ISI Thomson) with an h-Index (according to J. E. Hirsch) of 139 (according to Google Scholar). He is editor or member of editorial boards of more than 20 international scientific journals. Member of numerous professional societies and academies including American Academy of Microbiology, Berlin–Brandenburg Academy of Sciences and Humanities, German National Academy of Sciences Leopoldina, World Innovation Foundation and European Molecular Biology Organization. Numerous scientific awards.
Professor Kaufmann is Chair of the Board of the Schering Foundation. He was e. g. Chair of the Scientific Board of the Memento Prize and Member of the Executive Committee of the Robert Koch Foundation. He was Alternate Board Member of the Global Alliance for Vaccines and Immunisation (GAVI), was member of the Scientific Board of the Global Alliance for TB Drug Development (TB Alliance) and member of the Strategic Advisory Committee of the European and Developing Countries Clinical Trials Partnership (EDCTP). Stefan H. E. Kaufmann initiated the global Day of Immunology to raise public awareness in immunology. Scientific advisor on “Health” for the G7 summit in Elmau in 2015 as well as for the G20 summit in Hamburg in 2017.